Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.

Autor: Bounthavong, Mark1 (AUTHOR), Okamoto, Mark P.2 (AUTHOR)
Zdroj: Journal of Evaluation in Clinical Practice. Jun2007, Vol. 13 Issue 3, p453-460. 8p. 1 Diagram, 4 Charts, 3 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje